Skip to main content
. 2019 Jun 12;18(2):2073–2081. doi: 10.3892/ol.2019.10473

Figure 1.

Figure 1.

Upregulation of LIMD2 is associated with the progression of NSCLC. LIMD2 (A) mRNA and (B) protein was upregulated in NSCLC tissues compared with adjacent non-tumor tissues. *P<0.01 vs. adjacent. (C) The NSCLC patients with high LIMD2 expression exhibited shorter survival times than those with a low expression of LIMD2. (D) LIMD2 was upregulated in NSCLC cell lines compared to normal human lung epithelial BEAS-2B cells. **P<0.01 vs. BEAS-2B. NCSLC, non-small cell lung cancer; LIMD2, LIM domain containing 2.